The Cardiac Dysfunction Caused by Metabolic Alterations in Alzheimer's Disease
Authors:
Open Access
- 22 February 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 9, 850538
Abstract
A progressive defect in the energy generation pathway is implicated in multiple aging-related diseases, including cardiovascular conditions and Alzheimer's Disease (AD). However, evidence of the pathogenesis of cardiac dysfunction in AD and the associations between the two organ diseases need further elucidation. This study aims to characterize cellular defects resulting in decreased cardiac function in AD-model. 5XFAD mice, a strain expressing five mutations in human APP and PS1 that shows robust Aβ production with visible plaques at 2 months and were used in this study as a model of AD. 5XFAD mice and wild-type (WT) counterparts were subjected to echocardiography at 2-, 4-, and 6-month, and 5XFAD had a significant reduction in cardiac fractional shortening and ejection fraction compared to WT. Additionally, 5XFAD mice had decreased observed electrical signals demonstrated as decreased R, P, T wave amplitudes. In isolated cardiomyocytes, 5XFAD mice showed decreased fraction shortening, rate of shortening, as well as the degree of transient calcium influx. To reveal the mechanism by which AD leads to cardiac systolic dysfunction, the immunoblotting analysis showed increased activation of AMP-activated protein kinase (AMPK) in 5XFAD left ventricular and brain tissue, indicating altered energy metabolism. Mito Stress Assays examining mitochondrial function revealed decreased basal and maximal oxygen consumption rate, as well as defective pyruvate dehydrogenase activity in the 5XFAD heart and brain. Cellular inflammation was provoked in the 5XFAD heart and brain marked by the increase of reactive oxygen species accumulation and upregulation of inflammatory mediator activities. Finally, AD pathological phenotype with increased deposition of Aβ and defective cognitive function was observed in 6-month 5XFAD mice. In addition, elevated fibrosis was observed in the 6-month 5XFAD heart. The results implicated that AD led to defective mitochondrial function, and increased inflammation which caused the decrease in contractility of the heart.Keywords
Funding Information
- National Institute on Aging (R01AG049835, R21AG071249)
- National Heart, Lung, and Blood Institute (R01HL158515)
- National Institute of General Medical Sciences (R01GM124108)
This publication has 50 references indexed in Scilit:
- Activated protein C protects against myocardial ischemic/reperfusion injury through AMP‐activated protein kinase signalingJournal of Thrombosis and Haemostasis, 2011
- Assessing mitochondrial dysfunction in cellsBiochemical Journal, 2011
- Echocardiography in MiceCurrent Protocols in Mouse Biology, 2011
- Increased atherosclerosis and vascular inflammation in APP transgenic mice with apolipoprotein E deficiencyAtherosclerosis, 2010
- Energy expenditure and agingAgeing Research Reviews, 2010
- p53 Target Genes Sestrin1 and Sestrin2 Connect Genotoxic Stress and mTOR SignalingCell, 2008
- Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial functionProceedings of the National Academy of Sciences, 2007
- Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic MiceScience, 1996
- β-Amyloid-mediated vasoactivity and vascular endothelial damageNature, 1996
- Shortening fraction: its dependence on the Starling mechanismCardiovascular Research, 1981